Tag Archives: Lilly

Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease  Eli Lilly and Company Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity  CNBC Eli Lilly’s diabetes drug Mounjaro matches heart benefit of older treatment  statnews.com Eli Lilly Weight-Loss Drug Mounjaro …

Elli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk.  Barron’s Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease  Eli Lilly and Company Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity  CNBC Eli Lilly’s diabetes …

Eli Lilly: Competition Melts Away (NYSE:LLY)  Seeking Alpha Eli Lilly’s Orforglipron Study: A New Hope for Sleep Apnea and Obesity  TipRanks Eli Lilly’s Weight Management Study: A Potential Game-Changer in Obesity Treatment  TipRanks Eli Lilly’s Eloralintide Study: A New Frontier in Obesity Treatment  TipRanks Eli Lilly’s Orforglipron Study: A Potential Game-Changer for Diabetes and Obesity  TipRanks Source link